A U.K. committee has recommended adding a meningitis B vaccine made by Novartis to its immunization program, which could give the Swiss company's vaccines unit a welcome boost.
from WSJ.com: US Business http://ift.tt/OHePpx
via IFTTT
from WSJ.com: US Business http://ift.tt/OHePpx
via IFTTT
No comments:
Post a Comment